Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Net Margin: 2012-2025

Historic Net Margin for Agios Pharmaceuticals (AGIO) over the last 13 years, with Sep 2025 value amounting to -803.05%.

  • Agios Pharmaceuticals' Net Margin fell 1137774.00% to -803.05% in Q3 2025 from the same period last year, while for Sep 2025 it was -899.83%, marking a year-over-year decrease of 294143.00%. This contributed to the annual value of 1,845.92% for FY2024, which is 315856.00% up from last year.
  • As of Q3 2025, Agios Pharmaceuticals' Net Margin stood at -803.05%, which was up 11.13% from -903.60% recorded in Q2 2025.
  • In the past 5 years, Agios Pharmaceuticals' Net Margin ranged from a high of 10,574.69% in Q3 2024 and a low of -12,073.44% during Q1 2022.
  • Moreover, its 3-year median value for Net Margin was -1,037.61% (2025), whereas its average is -49.84%.
  • In the last 5 years, Agios Pharmaceuticals' Net Margin soared by 1,180,896bps in 2024 and then crashed by 1,137,774bps in 2025.
  • Agios Pharmaceuticals' Net Margin (Quarterly) stood at -2,150.44% in 2022, then spiked by 79,974bps to -1,350.70% in 2023, then skyrocketed by 45,113bps to -899.56% in 2024, then slumped by 1,137,774bps to -803.05% in 2025.
  • Its last three reported values are -803.05% in Q3 2025, -903.60% for Q2 2025, and -1,037.61% during Q1 2025.